Phlebotomy Lab Operations - Insights
PACE / State of FL Phlebotomy and specimen collection services are on the forefront of patient diagnosis. However, more often than not, they are over shadowed by testing laboratories because they deliver the final test results. The focus of...
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
February 2021 — Dermatopathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Dermatopathology.
Transfusion Decisions - Insights
PACE / State of FLIn this month’s “Virtual Lecture” Justin Kreuter, M.D., discusses how coagulation works and how to make appropriate transfusion decisions.
PACE / State of FLThis month’s “Virtual Lecture” recognizes the importance of tracking tumor cell development and the heterogeneity in cancer cell growth dynamics at the clonal resolution and reveals features of tumor cell metastasis.
Applications of Molecular Pathology and the Diagnosis of Soft Tissue Neoplasms - Insights
PACE / State of FLIn this month’s “Virtual Lecture” Andrew Folpe, M.D., discusses applications of molecular pathology and the diagnosis of soft tissue neoplasms. This presentation is applicable for pathologists because so much of what is...
Advancing our Understanding of Immunoglobulins to Better Understand Disease - Insights
PACE / State of FLIn this month’s “Virtual Lecture,” David Murray, M.D., Ph.D., discusses how immunoglobin light chains are used to detect overexpressed immunoglobins which can be applied to distinguish patients with plasma cell disorders...
Test panel guides diagnosis of early onset IBD: Ann Moyer, M.D., Ph.D. - Insights
Ann Moyer, M.D., Ph.D., explains how Mayo Clinic Laboratories' test panel provides comprehensive evaluation of patients with suspected monogenic early onset inflammatory bowel disease, or IBD. Accurate diagnosis is key to guiding therapy...
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D. - Insights
Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and...